Johns Hopkins nephrology director joins kidney disease startup

Renalytix AI, a company that develops artificial intelligence-enabled clinical diagnostics for kidney diseases, named Baltimore-based Johns Hopkins Medicine’s Chirag Parikh, MD, to its board.

Advertisement

Three notes:

1. Dr. Parikh is director of nephrology at Johns Hopkins School of Medicine.

2. His research focuses on the translation and validation of biomarkers for the diagnosis and prognosis of acute kidney injury.

3. Prior to joining Johns Hopkins, Dr. Parikh served as professor of medicine and investigative medicine at Yale University in New Haven, Conn. He also directed Yale’s applied translational research program.

More articles on health IT:
Florida women’s clinic alerts 520,000 patients of data breach
Alabama health system resumes services after week-long computer outage
Northwell extends Allscripts partnership: 3 notes

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The hidden cost of lost clinical time and how leading health systems are responding

Friday, August 7
12:00 PM - 1:00 PM CDT

Presenters: Kassaundra McKnight-Young, Zebra TechnologiesGregory Carras, Zebra TechnologiesJennifer Gene, Levata

Advertisement

Next Up in Health IT

Advertisement

Comments are closed.